SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-24-011220
Filing Date
2024-06-21
Accepted
2024-06-21 13:51:17
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-66327.html 4  
1 PRIMARY DOCUMENT marketforms-66327.xml 4 4127
  Complete submission text file 0001214659-24-011220.txt   5656
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Taglietti Marco (Reporting) CIK: 0001408870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 241059533